AstraZeneca PLC at ASCO Investor Meeting (Virtual) Transcript

Jun 05, 2023 / 11:00PM GMT
Andy Barnett - AstraZeneca PLC - VP, Global Head of IR

A warm welcome everybody to this 2023 ASCO event for investors and analysts, and thank you greatly for your continued focus and interest in our company. Just for your information, the presentation is now online. You can access it for those in the room by the QR code on your tables. You'll see all of our IR materials also listed in the same section.

Here's our forward-looking statement. Please familiarize yourselves with it if you haven't done so already. Here's the agenda for today's call. Our prepared remarks will be delivered in two sections with Q&As at the end of each section, breaking up some of the content, it will give you a chance to ask questions about particular subject matters in more depth.

The first section will focus predominately on lung cancer. And we're actually delighted to have Dr. Roy Herbst here with us for that section. So I know it will be hopefully very informative for all of us and useful to you in the room.

For those dialed in by Zoom, please use raise the hand function, feel free to ask

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot